Friday, 15 November 2019

Jazz Pharma's sleep disorder drug gets European panel backing

Jazz Pharmaceuticals Plc's treatment for a form of sleep disorder has been recommended for approval in Europe by a panel of the European Medicines Agency (EMA), the regulator said on Friday.


from Reuters: Health News https://ift.tt/2KqfYBB

No comments:

Post a Comment